XTL Biopharmaceutica Stock Forecast - Simple Regression

XTLB Stock  USD 2.10  0.22  11.70%   
The Simple Regression forecasted value of XTL Biopharmaceuticals Ltd on the next trading day is expected to be 1.66 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 9.50. XTL Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast XTL Biopharmaceutica stock prices and determine the direction of XTL Biopharmaceuticals Ltd's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of XTL Biopharmaceutica's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, XTL Biopharmaceutica's Receivables Turnover is projected to increase based on the last few years of reporting. The current year's Asset Turnover is expected to grow to 0.29, whereas Inventory Turnover is forecasted to decline to 0.000016. . The current year's Common Stock Shares Outstanding is expected to grow to about 572.2 M, whereas Net Loss is forecasted to decline to (1.6 M).
Simple Regression model is a single variable regression model that attempts to put a straight line through XTL Biopharmaceutica price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

XTL Biopharmaceutica Simple Regression Price Forecast For the 28th of December

Given 90 days horizon, the Simple Regression forecasted value of XTL Biopharmaceuticals Ltd on the next trading day is expected to be 1.66 with a mean absolute deviation of 0.15, mean absolute percentage error of 0.04, and the sum of the absolute errors of 9.50.
Please note that although there have been many attempts to predict XTL Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that XTL Biopharmaceutica's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

XTL Biopharmaceutica Stock Forecast Pattern

Backtest XTL BiopharmaceuticaXTL Biopharmaceutica Price PredictionBuy or Sell Advice 

XTL Biopharmaceutica Forecasted Value

In the context of forecasting XTL Biopharmaceutica's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. XTL Biopharmaceutica's downside and upside margins for the forecasting period are 0.02 and 9.50, respectively. We have considered XTL Biopharmaceutica's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
2.10
1.66
Expected Value
9.50
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of XTL Biopharmaceutica stock data series using in forecasting. Note that when a statistical model is used to represent XTL Biopharmaceutica stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria116.7393
BiasArithmetic mean of the errors None
MADMean absolute deviation0.1532
MAPEMean absolute percentage error0.0834
SAESum of the absolute errors9.5007
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as XTL Biopharmaceuticals Ltd historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for XTL Biopharmaceutica

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as XTL Biopharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.112.119.94
Details
Intrinsic
Valuation
LowRealHigh
0.081.699.52
Details

Other Forecasting Options for XTL Biopharmaceutica

For every potential investor in XTL, whether a beginner or expert, XTL Biopharmaceutica's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. XTL Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in XTL. Basic forecasting techniques help filter out the noise by identifying XTL Biopharmaceutica's price trends.

XTL Biopharmaceutica Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with XTL Biopharmaceutica stock to make a market-neutral strategy. Peer analysis of XTL Biopharmaceutica could also be used in its relative valuation, which is a method of valuing XTL Biopharmaceutica by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

XTL Biopharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of XTL Biopharmaceutica's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of XTL Biopharmaceutica's current price.

XTL Biopharmaceutica Market Strength Events

Market strength indicators help investors to evaluate how XTL Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading XTL Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying XTL Biopharmaceutica stock market strength indicators, traders can identify XTL Biopharmaceuticals Ltd entry and exit signals to maximize returns.

XTL Biopharmaceutica Risk Indicators

The analysis of XTL Biopharmaceutica's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in XTL Biopharmaceutica's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting xtl stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether XTL Biopharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of XTL Biopharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xtl Biopharmaceuticals Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xtl Biopharmaceuticals Ltd Stock:
Check out Historical Fundamental Analysis of XTL Biopharmaceutica to cross-verify your projections.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XTL Biopharmaceutica. If investors know XTL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XTL Biopharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Earnings Share
(0.03)
Return On Assets
(0.14)
Return On Equity
(0.13)
The market value of XTL Biopharmaceuticals is measured differently than its book value, which is the value of XTL that is recorded on the company's balance sheet. Investors also form their own opinion of XTL Biopharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is XTL Biopharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XTL Biopharmaceutica's market value can be influenced by many factors that don't directly affect XTL Biopharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XTL Biopharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if XTL Biopharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XTL Biopharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.